Design and synthesis of naphthalenic dimers as selective MT1 melatoninergic ligands

被引：56

作者：

Descamps-François, C

Yous, S

Chavatte, P

Audinot, V

Bonnaud, A

Boutin, JA

Delagrange, P

Bennejean, C

Renard, P

Lesieur, D

机构：

[1] Univ Lille 2, Fac Pharm, Chim Therapeut Lab, F-59006 Lille, France

[2] Inst Rech Int Serv, Courbevoie, France

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2003年 / 46卷 / 07期

关键词：

D O I：

10.1021/jm0255872

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

We report the synthesis and binding properties at MT1 and MT2 receptors of the first example of agomelatine (N-[2-(7-methoxynaphth-1-yl)ethyl] acetamide) dimers in which two agomelatine moieties are linked together through their methoxy substituent by a polymethylene side chain according to the "bivalent ligand" approach. Some of these compounds behave as MT1-selective ligands. The most selective one (5) behaves as an antagonist.

引用

收藏

页码：1127 / 1129

页数：3

相关论文

共 29 条

[1] Melatonin receptor subtype expression in human cerebellum [J].

Al-Ghoul, WM ;

Herman, MD ;

Dubocovich, ML .

NEUROREPORT, 1998, 9 (18) :4063-4068

[2] Monitoring of ligand-independent dimerization and ligand-induced conformational changes of melatonin receptors in living cells by bioluminescence resonance energy transfer [J].

Ayoub, MA ;

Couturier, C ;

Lucas-Meunier, E ;

Angers, S ;

Fossier, P ;

Bouvier, M ;

Jockers, R .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (24) :21522-21528

[3] Functional expression of MT2 (Mel1b) melatonin receptors in human PAZ6 adipocytes [J].

Brydon, L ;

Petit, L ;

Delagrange, P ;

Strosberg, AD ;

Jockers, R .

ENDOCRINOLOGY, 2001, 142 (10) :4264-4271

[4] SYNTHESIS AND STRUCTURE-ACTIVITY-RELATIONSHIPS OF NOVEL NAPHTHALENIC AND BIOISOSTERIC RELATED AMIDIC DERIVATIVES AS MELATONIN RECEPTOR LIGANDS [J].

DEPREUX, P ;

LESIEUR, D ;

MANSOUR, HA ;

MORGAN, P ;

HOWELL, HE ;

RENARD, P ;

CAIGNARD, DH ;

PFEIFFER, B ;

DELAGRANGE, P ;

GUARDIOLA, B ;

YOUS, S ;

DEMARQUE, A ;

ADAM, G ;

ANDRIEUX, J .

JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (20) :3231-3239

[5] Melatonin mediates two distinct responses in vascular smooth muscle [J].

Doolen, S ;

Krause, DN ;

Dubocovich, ML ;

Duckles, SP .

EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 345 (01) :67-69

[6]

Dubocovich M.L., 2000, IUPHAR COMPENDIUM RE, P271

[7] Melatonin receptor antagonists that differentiate between the human Mel(1a), and Mel(1b) recombinant subtypes are used to assess the pharmacological profile of the rabbit retina ML(1) presynaptic heteroreceptor [J].

Dubocovich, ML ;

Masana, MI ;

Iacob, S ;

Sauri, DM .

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1997, 355 (03) :365-375

[8] NARCOTIC ANTAGONISTIC POTENCY OF BIVALENT LIGANDS WHICH CONTAIN BETA-NALTREXAMINE - EVIDENCE FOR BRIDGING BETWEEN PROXIMAL RECOGNITION SITES [J].

EREZ, M ;

TAKEMORI, AE ;

PORTOGHESE, PS .

JOURNAL OF MEDICINAL CHEMISTRY, 1982, 25 (07) :847-849

[9] Mapping the melatonin receptor.: 6.: Melatonin agonists and antagonists derived from 6H-isoindolo[2,1-a]indoles, 5,6-dihydroindolo[2,1-a]isoquinolines, and 6,7-dihydro-5H-benzo[c]azepino[2,1-a]indoles [J].

Faust, R ;

Garratt, PJ ;

Jones, R ;

Yeh, LK ;

Tsotinis, A ;

Panoussopoulou, M ;

Calogeropoulou, T ;

Teh, MT ;

Sugden, D .

JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (06) :1050-1061

[10] N,N-6-BIS-[2-(3,4-DIHYDROXYBENZYL)PYRROLIDINYL]HEXANE, A POTENT, SELECTIVE, ORALLY-ACTIVE DOPAMINE ANALOG WITH HYPOTENSIVE AND DIURETIC ACTIVITY [J].

FISHER, LE ;

ROSENKRANZ, RP ;

CLARK, RD ;

MUCHOWSKI, JM ;

MCCLELLAND, DL ;

MICHEL, A ;

CAROON, JM ;

GALEAZZI, E ;

EGLEN, R ;

WHITING, RL .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1995, 5 (20) :2371-2376